2026-01-12 - Analysis Report
### UNH: Company Overview
UnitedHealth Group Inc (UNH) is a healthcare services organization.

### Report Overview

#### Financial Metrics

* **Return Rate of Review Stock:** -18.45%
* **Return Rate of Comparison Stock (S&P 500, VOO):** 94.03%
* **Divergence (Cumulative Return on Last Day):** -112.50

#### Simple Numbers

* **5-day SMA:** $344.70
* **20-day SMA:** $335.08
* **60-day SMA:** $335.89
* **Recent Market Close:** $343.98
* **Price Change:** -0.83
* **Market Risk Indicator (MRI):** 0.70
* **RSI:** 65.03
* **PPO:** 0.54
* **Expected Return (%):** -274.70%

#### 2016-2025 CAGR, MDD, Alpha, Beta Analysis

| Period | CAGR | MDD | Alpha | Beta | Capital |
| ------ | ---- | --- | ------ | ------> | ------> |
| 2016-2018 | 22.0% | 18.6% | 19.0% | 0.9 | 225.7B |
| 2017-2019 | 27.0% | 18.6% | 10.0% | 0.9 | 266.3B |
| 2018-2020 | -41.0% | 32.5% | -62.0% | 1.1 | 317.7B |
| 2019-2021 | 16.0% | 32.5% | -27.0% | 1.1 | 454.9B |
| 2020-2022 | 0.0% | 31.5% | 2.0% | 0.9 | 480.3B |
| 2021-2023 | 23.0% | 13.4% | 23.0% | 0.5 | 476.9B |
| 2022-2024 | -24.0% | 23.1% | -44.0% | 0.4 | 458.2B |
| 2023-2025 | -55.0% | 58.5% | -118.0% | 0.3 | 299.0B |

### Recent Stock Price Fluctuations

The recent stock price fluctuates, with the 5-day, 20-day, and 60-day moving averages at $344.70, $335.08, and $335.89 respectively.

### Analyst Opinions

* **Analyst Consensus: Buy**
* **Mean: 1.93 (~Buy)**
* **Opinions: 26**
* **Target Price (avg/high/low): 393.85 / 444.00 / 280.00**

### Recent Earnings Analysis

| Date     | EPS | Revenue |
| ------>  |---->| ------> |
| 2025-10-28 | 2.59 | 113.16 B$ |
| 2025-08-11 | 3.76 | 111.62 B$ |
| 2025-05-07 | 6.9 | 109.58 B$ |
| 2024-11-04 | 6.56 | 100.82 B$ |

Recent EPS: 2.59, Revenue: $113.16B

### Revenue and Profitability

| Quarter | Revenue | Profit Margin |
| ------> | ------> | ------> |
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

### Capital and Profitability

| Quarter | Equity | ROE |
| ------> | ------> | ------> |
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

### Comprehensive Analysis

Recent trends suggest UNH's stock price is declining. The company's financial metrics show a decrease in return rate compared to the S&P 500. Analyst opinions are generally positive, with a consensus to buy. Recent earnings and financial data indicate a slight decline in profit margin and revenue. Overall, the company's financial situation appears challenging.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.